Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.
January 2026 in “Biomaterials Science” The formulation helps improve wound healing and skin repair.
January 2026 in “Clinical Cosmetic and Investigational Dermatology” Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.
January 2026 in “Academic Journal of Medicine & Health Sciences” Phage therapy could be a safe and effective new treatment for acne.
January 2026 in “RSC Advances” The hydrogel speeds up diabetic wound healing and reduces scarring.
December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.
December 2025 in “Cureus” "Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.
December 2025 in “International Research Journal on Advanced Engineering and Management (IRJAEM)” AI improves cosmetic surgery but requires ethical and legal oversight to ensure safe use.
December 2025 in “International Journal of Pharmacology” iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.
December 2025 in “Frontiers in Medicine” Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.